Establishment of PDX-derived oral cancer cell lines and utility of anti-HER2 antibody therapy

被引：0
|
作者：
Seki, Yuki [1 ]
Kariya, Ryusyo [2 ]
Yoshida, Ryoji [3 ]
Kawahara, Kenta [3 ]
Hirayama, Masatoshi [3 ]
Nakamoto, Masafumi [3 ]
Hirosue, Akiyuki [3 ]
Okada, Seiji [2 ]
Nakayama, Hideki [3 ]
机构：
[1] Kumamoto Univ, Grad Sch Med Sci, Kumamoto, Japan
[2] Kumamoto Univ, Div Hematopoiesis Joint Res Ctr Human Retrovirus, Kumamoto, Japan
[3] Kumamoto Univ, Fac Life Sci, Dept Oral & Maxillofac Surg, Kumamoto, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2238
引用
收藏
页码：990 / 990
页数：1
相关论文
共 50 条
  • [1] Establishment of PDX model of oral cancer and PDX-derived cell lines, and usefulness of anti-HER2 antibody therapy
    Seki, Yuki
    Kariya, Ryusho
    Yoshida, Ryoji
    Kawahara, Kenta
    Hirayama, Masatoshi
    Takahashi, Nozomu
    Nakamoto, Masafumi
    Takeshita, Hisashi
    Okada, Seiji
    Nakayama, Hideki
    CANCER SCIENCE, 2024, 115 : 1074 - 1074
  • [2] Establishment of matched bladder cancer PDX and PDX-derived organoid model and evaluation of anti-tumor efficacy of abemaciclib
    Lu, Xiongbing
    Hu, Chao
    Duan, Lingxing
    Chen, Ke
    Hao, Hua
    He, Yuanqiao
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 2207 - 2219
  • [3] HER2 testing and its predictive utility in anti-HER2 breast cancer therapy
    Advani, Pooja P.
    Crozier, Jennifer A.
    Perez, Edith A.
    BIOMARKERS IN MEDICINE, 2015, 9 (01) : 35 - 49
  • [4] Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)
    Büchler, P
    Reber, HA
    Büchler, MC
    Roth, MA
    Büchler, MW
    Friess, H
    Isacoff, WH
    Hines, OJ
    JOURNAL OF GASTROINTESTINAL SURGERY, 2001, 5 (02) : 139 - 146
  • [5] Anti-HER2 Cancer Therapy and Cardiotoxicity
    Babar, Tania
    Blomberg, Christopher
    Hoffner, Eileen
    Yan, Xinhua
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (30) : 4911 - 4919
  • [6] Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin)
    Peter Büchler
    Howard A. Reber
    Manuela C. Bückler
    Mendel A. Roth
    Markus W. Büchler
    Helmut Friess
    William H. Isacoff
    Oscar J. Hines
    Journal of Gastrointestinal Surgery, 2001, 5 : 139 - 146
  • [7] Adjuvant anti-HER2 monoclonal antibody therapy - ready for breast cancer?
    Perez, EA
    BREAST, 2001, 10 : 161 - 163
  • [8] Anti-HER2 monoclonal antibody therapy with adjuvant chemotherapy for breast cancer
    Perez, Edith A.
    ANNALS OF ONCOLOGY, 2006, 17 : 39 - 39
  • [9] Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinoma
    Aoyama, Jun
    Nojima, Yusuke
    Sano, Daisuke
    Hirai, Yuri
    Kijima, Natsumi
    Aizawa, Yoshihiro
    Takada, Kentaro
    Hatano, Takashi
    Takahashi, Hideaki
    Nishimura, Goshi
    Oridate, Nobuhiko
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (07): : 1801 - 1811
  • [10] A preclinical platform of breast cancer PDX-derived cell lines as a tool for pharmacological screening and functional studies
    Cairo, Stefano
    Deas, Olivier
    Banis, Sophie
    Flosseau, Kathleen
    Le Ven, Enora
    Judde, Jean-Gabriel
    CANCER RESEARCH, 2021, 81 (04)
12345